Carregant...
Extended Adjuvant Aromatase Inhibitor Therapy in Post-Menopausal Women
PURPOSE OF THE REVIEW: To understand the evidence for extending adjuvant aromatase inhibitor (AI) therapy from 5 to 10 years in post-menopausal women with hormone receptor positive (HR+) breast cancer. RECENT FINDINGS: Multiple large trials have investigated this question. The two trials most repres...
Guardat en:
| Publicat a: | Curr Breast Cancer Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5791913/ https://ncbi.nlm.nih.gov/pubmed/29399271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12609-017-0260-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|